Financial Performance - The company's revenue for Q3 2024 was ¥249,439,690.32, representing a 0.17% increase year-over-year, while the year-to-date revenue reached ¥703,267,200.50, up 11.17% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥14,393,823.52, a decrease of 31.69% year-over-year, with year-to-date net profit at ¥46,472,123.82, down 10.90%[2] - Basic earnings per share for Q3 2024 was ¥0.1295, reflecting a decline of 31.15% compared to the same quarter last year[6] - Total operating revenue for Q3 2024 reached CNY 703,267,200.50, an increase of 11.14% compared to CNY 632,611,777.21 in the same period last year[15] - Net profit for Q3 2024 was CNY 46,472,287.89, a decrease of 12.24% from CNY 53,105,512.75 in Q3 2023[16] - The total comprehensive income for the period was CNY 46,472,287.89, compared to CNY 53,105,512.75 in the previous period, representing a decrease of approximately 12.3%[17] - The basic and diluted earnings per share were both CNY 0.4163, down from CNY 0.4657 in the previous period, indicating a decline of about 10.5%[17] Assets and Liabilities - The total assets at the end of Q3 2024 amounted to ¥1,668,496,616.50, showing a slight decrease of 0.42% from the end of the previous year[2] - The company's total assets as of the end of Q3 2024 were CNY 1,668,496,616.50, slightly down from CNY 1,675,470,799.44 at the end of Q3 2023[15] - Total liabilities decreased to CNY 717,335,555.60 from CNY 764,600,977.34, indicating a reduction of 6.19% year-over-year[15] - The equity attributable to shareholders of the parent company increased to CNY 950,719,035.17, compared to CNY 909,144,858.30 in the same period last year, reflecting a growth of 4.57%[15] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥101,374,434.33, down 9.54% compared to the same period last year[2] - Cash inflows from operating activities totaled CNY 676,136,302.70, an increase of 23.8% from CNY 546,305,341.10 in the previous period[19] - The net cash flow from operating activities was CNY 101,374,434.33, a decrease of 9.8% compared to CNY 112,066,005.89 in the previous period[19] - Cash outflows for purchasing goods and services amounted to CNY 399,706,697.31, up from CNY 265,414,002.50, reflecting a significant increase of 50.5%[19] - The net cash flow from investing activities was -CNY 100,027,926.62, slightly improved from -CNY 101,058,863.45 in the previous period[19] - Cash inflows from financing activities were CNY 75,218,227.04, a decrease of 83.0% from CNY 441,535,791.66 in the previous period[19] - The net cash flow from financing activities was -CNY 75,653,673.58, contrasting sharply with a positive net flow of CNY 363,152,414.67 in the previous period[19] - The ending balance of cash and cash equivalents was CNY 438,016,387.75, down from CNY 529,219,292.41 in the previous period, indicating a decrease of approximately 17.3%[19] Shareholder Information - The total number of common shareholders at the end of the reporting period was 8,868, with the largest shareholder holding 43.71% of the shares[7] - The company’s major shareholder, Zhang Yi, holds 48,967,982 shares, representing 43.71% of the total shares[11] - The total number of shares held by the top 10 shareholders increased to 64,743,375, with a total of 18,545,972 shares added during the period[11] Operational Insights - The company has not reported any new product developments or significant market expansion strategies during this quarter[5] - There were no significant mergers or acquisitions disclosed in the current report[5] - The company received a total of RMB 9,605,937.60 from 33 incentive participants for the first vesting period of the restricted stock incentive plan, with RMB 782,880.00 allocated to share capital and RMB 8,823,057.60 to capital reserves[12] - The total number of restricted shares vested was 782,880, which were listed for trading on October 15, 2024[12] - The company’s total restricted shares before the vesting period amounted to 46,364,932 shares, with no shares released during the current period[11] Research and Development - Research and development expenses increased to CNY 43,326,096.42, compared to CNY 31,810,848.94 in the previous year, marking a rise of 36.25%[16] Financial Reporting - The report for the third quarter was not audited, which may impact the reliability of the financial data presented[20]
纽泰格(301229) - 2024 Q3 - 季度财报